Select Language
Register for the International Review of Psychosis and Bipolarity Conference

International Review of Psychosis & Bipolarity

Athens, Greece, 9-12 May 2014


Chair: Prof Konstantinos Fountoulakis

Co-Sponsored Scientific Meeting by the World Psychiatric Association  International Society of Neurobiology and Psychopharmacology  Hellenic Psychiatric Association
LATEST NEWS:

Important Deadlines

Early Registration 1
31 December 2013

Oral Presentation Submissions
7th February 2014

Oral Presentation Approvals
23 February 2014

Early Registration 2
1st March 2014

Bursary Requests
7 March 2014

Bursary Approvals
21 March 2014

Final Posters
23 April 2014

Platinum Sponsors

Silver Sponsors

Grants provided by

Exhibitors

Speaker Biographies

The IFPB is delighted to announce the following speakers for IRPB Athens 2014.

Prof John Kelsoe (USA)
Prof John Kelsoe (USA)

Professor of Psychiatry at the University of California, San Diego.

Biography
Dr. Kelsoe graduated from medical school at the University of Alabama, Birmingham in 1981. He completed internship training at Washington University in St. Louis and psychiatry residency at UCSD. He then went to the National Institute of Mental Health in Bethesda, Maryland for 4 years and returned to San Diego to join the Department of Psychiatry faculty in 1989.

Research Focus
Dr. Kelsoe’s longstanding research focus has been the genetics of psychiatric illness, bipolar disorder in particular. Over the past 20 years, his work has been focused on using a variety of molecular genetic methods to identify the specific genes that predispose to bipolar disorder. He has pursued this primarily by using positional cloning methods such as linkage and association in families in which the illness is genetically transmitted. He has also employed animal models of bipolar disorder in order to identify possible candidate genes that can then be tested in clinical populations. This approach has led to the recent identification of the gene for G protein receptor kinase 3 (GRK3) as a likely gene for bipolar disorder on chromosome 22. Dr. Kelsoe is currently actively engaged in genome wide association studies of bipolar disorder. He directs the Bipolar Genome Study (BiGS) which is a 13-site consortium focused on identifying genes for bipolar disorder and their relationship to clinical symptoms. He also co-directs the Psychiatric GWAS Consortium for Bipolar Disorder (PGC-BD) which is an international collaborative effort designed to identify genes for bipolar disorder in a sample of over 10,000 patients. These large exciting new technological approaches promise great advances in understanding the causes of bipolar disorder.

Clinical Focus
Dr. Kelsoe’s primary clinical focus is the treatment of refractory mood disorders. He is the Medical Director of the STEP Clinic at the VA Hospital where they specialize in the treatment of chronic and refractory mood disorders. Patients at this clinic receive a thorough diagnostic evaluation and are eligible to participate in longitudinal research studies of the ability of genes to predict course, outcome, and treatment response.






Page Last Updated : 11-11-2013

CME ACCREDITATION SERVICES

CME Accreditation Services
click on the image above for more information

CME Accreditation

IRPB 2014 has been awarded 26 CME accreditation points by the International Forum of Psychosis & Bipolarity.

Delegates should only award themselves 1 CME accreditation point per 1 hour spent at the conference.

Keep me updated

A value is required.
A value is required.
A value is required.Invalid format.
A value is required.
CAPTCHA Image

Your privacy is important to us

SHARING

Twitter
  • PayPal Acceptance Mark

London | Lisbon | Valencia | Budapest | Nicosia | Dubai | Hong Kong

  • © Copyright 2010 - 2013 IFPB LTD. All rights reserved.

Website Design Chesterfield: MGF.net π